Skip to Content

Join the 'Upper Limb Spasticity' group to help and get support from people like you.

Upper Limb Spasticity News

Stem Cell Transplant for MS Shows Promise

Posted 19 Mar 2018 by Drugs.com

A stem cell transplant may be an effective treatment for multiple sclerosis, an international study suggests. The treatment involves using cancer drugs to decimate a patient's immune system and then restarting it with a stem cell transplant, BBC News reported. The study included 100 patients in the United States, England, Sweden and Brazil with relapsing remitting MS, in which attacks are ...

Eating Fish Might Guard Against MS

Posted 2 Mar 2018 by Drugs.com

THURSDAY, March 1, 2018 – People who eat fish regularly seem to have a lower risk of developing multiple sclerosis, researchers report. How much fish makes a difference? In this study, people who ate fish at least once a week – or who ate fish one to three times a month and took daily fish oil supplements – had a 45 percent lower risk of developing multiple sclerosis (MS) compared to folks who ...

MS Drug Tysabri (Natalizumab) Poses Hard Choices for Women Wanting Children

Posted 8 Feb 2018 by Drugs.com

THURSDAY, Feb. 8, 2018 – A powerful multiple sclerosis drug presents women with a tough dilemma if they would like to have children, a pair of new studies suggests. Those who take Tysabri (natalizumab) to manage their MS are more likely to suffer a relapse during pregnancy if they stop taking the drug before they conceive, the first study found. But if a woman remains on Tysabri while trying to ...

MS Patients May Gain From Balance-Focused Workouts

Posted 1 Feb 2018 by Drugs.com

WEDNESDAY, Jan. 31, 2018 – Problems with balance are a common hallmark of multiple sclerosis, but new research suggests a specially designed exercise program can help put patients on firmer ground. People with MS who enrolled in the 14-week program showed "greater improvements in balance, dizziness and fatigue," compared to MS patients who hadn't done the exercises. That's according to a team ...

Healthy Living May Ease Some MS Symptoms

Posted 7 Dec 2017 by Drugs.com

WEDNESDAY, Dec. 6, 2017 – The old adage that "an apple a day keeps the doctor away" appears to be at least partly true for people living with multiple sclerosis (MS). New research suggests that a healthy diet – one that's chock-full of fruits, vegetables and whole grains but contains little added sugars and red or processed meats – was associated with a reduced risk for disability. The study ...

Controversial MS Treatment Procedure Found to Be Ineffective

Posted 27 Nov 2017 by Drugs.com

MONDAY, Nov. 27, 2017 – The main proponent of a controversial treatment for multiple sclerosis now has declared the therapy to be worthless. For nearly a decade, Italian researcher Dr. Paolo Zamboni investigated inadequate blood flow as a potential cause of MS and has promoted reopening the veins that serve the central nervous system as a possible means of treating the progressive neural ...

High-Fat Diets Could Pose Danger to Young MS Patients

Posted 10 Oct 2017 by Drugs.com

TUESDAY, Oct. 10, 2017 – A fatty diet may up the risk of relapse in children with multiple sclerosis, according to a new study. But eating a diet rich in vegetables could cut relapse risk in half, the researchers found. The findings may provide early evidence that dietary changes could help some patients with MS manage their condition, said the research team led by Dr. Emmanuelle Waubant. She's ...

Clues to MS May Lurk in Gut Bacteria

Posted 12 Sep 2017 by Drugs.com

TUESDAY, Sept. 12, 2017 – Certain types of bacteria in the gut may play a role in the progression of multiple sclerosis, according to researchers working with mice. The research, the study authors believe, could lead to new ways to treat multiple sclerosis (MS), an autoimmune neurodegenerative disease that affects about 2.5 million people worldwide. "The [gut] microbiome is very malleable," ...

Resistance Training May Slow MS, Study Says

Posted 4 Aug 2017 by Drugs.com

FRIDAY, Aug. 4, 2017 – Resistance training may help slow progression of multiple sclerosis, a small study suggests. "Among persons with multiple sclerosis, the brain shrinks markedly faster than normal," said study researcher Ulrik Dalgas. "Drugs can counter this development, but we saw a tendency that training further minimizes brain shrinkage in patients already receiving medication." ...

Breast-Feeding May Lower Risk of MS, Study Says

Posted 12 Jul 2017 by Drugs.com

WEDNESDAY, July 12, 2017 – Women with a longer history of breast-feeding may be less likely to develop multiple sclerosis than mothers who skip breast-feeding or nurse for briefer periods, a new study suggests. Researchers compared nearly 400 women with MS or its precursor, known as clinically isolated syndrome (CIS), with a similar healthy group. They found that mothers who had breast-fed one ...

MS-Related Brain Changes May Affect Social Skills

Posted 1 Jun 2017 by Drugs.com

THURSDAY, June 1, 2017 – Subtle brain changes may explain why some people with multiple sclerosis (MS) lose their ability to interpret clues about what other people are thinking and feeling, a new study suggests. Until now, there has been little study of the way MS affects the so-called "social brain." Portuguese researchers wanted to learn why some people with MS develop a social disconnect ...

Immune-Based Therapy Shows Early Promise Against MS

Posted 21 Apr 2017 by Drugs.com

THURSDAY, April 20, 2017 – An experimental immune-system therapy appears safe for people with progressive forms of multiple sclerosis. And it may ease symptoms in some, a preliminary study suggests. The findings are based on just six patients, and the Australian researchers stressed that a lot of work still lies ahead. But they were encouraged that this new approach to MS had no major side ...

Ocrevus Approved to Treat Severe Form of Multiple Sclerosis

Posted 29 Mar 2017 by Drugs.com

WEDNESDAY, March 29, 2017 – The injected drug Ocrevus (ocrelizumab) has been approved by the U.S. Food and Drug Administration to treat adults with primary progressive multiple sclerosis (PPMS) and relapsing forms of the disease, the agency said Wednesday in a news release. MS is an inflammatory autoimmune disease of the central nervous system, characterized by periods of active symptoms ...

FDA-OK'd Ocrevus Offers Hope to Sickest MS Patients

Posted 29 Mar 2017 by Drugs.com

WEDNESDAY, March 29, 2017 – A new multiple sclerosis drug approved by the U.S. Food and Drug Administration late Tuesday offers hope to patients with the most severe form of the progressive disease. The intravenous drug, made by Genentech, is called ocrelizumab (Ocrevus). Given every six months, it worked best for patients with relapsing multiple sclerosis (MS) – the most common form of the ...

Controversial MS Treatment Seems Ineffective

Posted 8 Mar 2017 by Drugs.com

WEDNESDAY, March 8, 2017 – An invasive multiple sclerosis treatment called liberation therapy is not only costly, it's also ineffective, new research contends. Since 2009, thousands of multiple sclerosis (MS) patients have undergone the controversial treatment. Liberation therapy involves opening up narrowed veins from the brain and spinal cord. However, many specialists have had doubts about ...

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Spasticity

Related Drug Support Groups

Botox, Dysport, onabotulinumtoxina, abobotulinumtoxina, incobotulinumtoxina, Xeomin